This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit




















Not an AzPA member?

Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings.


 


AREA & ASSOCIATION NEWS

Influenza activity in Arizona continues to be elevated
AzPA
The first influenza-associated pediatric death in Arizona for the 2013-2014 season was identified this week. A Yuma County child had an influenza A pdm09 infection, as confirmed by polymerase chain reaction test at the Arizona State Public Health Laboratory. The child had underlying medical conditions, and the case investigation is ongoing.

We would like to remind everyone that it is not too late to get a flu shot. Influenza vaccination is the best prevention against flu, and influenza activity in Arizona usually lasts through the spring months. National data indicate that this year's vaccine is a good match to the circulating viruses. Flu vaccination locations and other information can be found online. Physicians should remind their patients to stay home when they are sick and to use good respiratory etiquette to prevent the spread of influenza. If you have any questions, please contact your local health department.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Pharmacy Day at the State Capitol — PD@C Feb. 12
AzPA
New this year! Free law CE: Grassroots Involvement in the Policymaking Process
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




AzPA Psychiatric Certificate Program — Assessing, Monitoring, and Managing Patients with Psychiatric DisordersCertificate
AzPA



Date: March 7
Location: Hilton El Conquistador, Tucson, Ariz.
Click here to learn more.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


47th Annual Southwestern Clinical Pharmacy Seminar — March 7-9
AzPA
We are pleased to announce a partnership with The University of Arizona College of Pharmacy and the Arizona Pharmacy Association in offering the 47th Annual Southwestern Clinical Pharmacy Seminar.






Keynote General Session
Saturday, March 8
Pharmacists as Providers

Guest Speakers:

Thomas Menighan, BSPharm, MBA, Sc.D.,
Executive Vice President and CEO,
American Pharmacists Association
and
David Chen, R.Ph., MBA, Director,
Pharmacy Practice Sections and Director,
Section of Pharmacy Practice Managers,
American Society of Health-System Pharmacists

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE



PHARMACY UPDATES


Cannabis craze: A pharmacist's take on medical marijuana
By Jason Poquette
It is no exaggeration to say our nation is presently obsessed with the issues surrounding availability and access to marijuana. Presently, 20 states allow for the medical use of marijuana. Two states, Colorado and Washington, allow for the purchase of marijuana for recreational use. Nine more states have legislation pending on the matter. It is no small project to weed through (pun intended) all the various political, legal, economic, scientific and ethical issues that inevitably arise in any candid discussion about our current cannabis craze. As a pharmacist, I am concerned about the issue on a practical level.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Patients highly satisfied at independent pharmacies
NCPA
Readers of Consumer Reports magazine gave independent community pharmacies high marks for overall customer satisfaction and the best ratings of any pharmacy provider in key categories such as speed and accuracy, courtesy and helpfulness, and pharmacists' knowledge, according to the publication's pharmacy survey, featured in the March issue of the magazine.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Top 100 selling drugs of 2013
Medscape
Hypothyroid medication levothyroxine was the nation's most prescribed drug in 2013, whereas the antipsychotic aripiprazole had the highest sales, at nearly $6.5 billion, according to a new report from research firm IMS Health on the top 100 selling drugs in the United States.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Medication problems: Taking drugs at wrong times (APhA)
Real-time insight into how fast a living body metabolizes drugs, opening the door to highly personalized medicine (Medical News Today)
Drug information education for practicing physicians: Part II (By Mike Wokasch)

Don't be left behind. Click here to see what else you missed.


IN THE NEWS


Encouragement from pharmacists improves COPD and asthma medication use
Pharmacy Times
No matter how many times pharmacists educate patients about inhalers, additional counseling and technique review is critical. Patients forget how to use their inhalers, slip into sloppy technique or become non-adherent to necessary medication. Encouraging words from pharmacists can improve adherence. In addition, pharmacist review of patients’ drug profiles often identifies inappropriate drug use in asthma and chronic obstructive pulmonary disease patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study: Epidural may beat patient-controlled painkiller for childbirth
HealthDay News
Epidurals are better pain relievers during labor than patient-controlled doses of a fast-acting painkiller called remifentanil, new research suggests.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New hypertension guidelines may simplify treatment
AJHP via ASHP
Clinicians now have two new guidelines on which to base hypertension treatment recommendations. The 17-member Eighth Joint National Committee released its hypertension treatment guidelines in mid-December. Also released at that time were guidelines created by a 25-member international panel and endorsed by the American Society of Hypertension and the International Society of Hypertension.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
Study: Epidural may beat patient-controlled painkiller for childbirth
HealthDay News
Epidurals are better pain relievers during labor than patient-controlled doses of a fast-acting painkiller called remifentanil, new research suggests.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Pharmacists conduct flu, strep tests
Supermarket News
Eighty Midwest pharmacies are taking part in a study aimed at improving patient outcomes by having specially trained pharmacists conduct free flu and strep throat tests, and in some, cases fill matching prescriptions.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Medication problems: Taking drugs at wrong times
APhA
"Lynette" was taking 16 different medications. Some were for hypertension, others for diabetes, and others still for heart disease, along with a handful of supplements.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


MEDICATION UPDATES


A less toxic therapy for low-risk breast cancer
Pharmacy Practice News
A new study has demonstrated that treatment with adjuvant paclitaxel and trastuzumab is highly effective in patients with stage I, node-negative, HER2-positive breast cancer. Although this finding comes from a Phase II trial, clinicians believe it will have a great influence on practice.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Adherence to all prescriptions after heart attack improves outcomes
Pharmacy Times
Post-myocardial infarction patients who had each of their preventive medications on hand at least 80 percent of the time had significantly lower rates of major vascular events or revascularization than controls.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword MEDICATION ADHERENCE.




FDA considers loosening naproxen's CV warning
Medscape
Data published since 2006 suggest that naproxen does not pose the same cardiovascular risks as other nonsteroidal anti-inflammatory drugs, according to Food and Drug Administration reviewers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA will review safety of testosterone therapy
HealthDay News
Spurred by a recent report that popular testosterone treatments might raise men's heart risk, the FDA says it now plans a review of the therapies' safety. "FDA is investigating the risk of stroke, heart attack and death in men taking FDA-approved testosterone products," the agency said in a recent statement.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Jan. 29, 2014
Jan. 22, 2014
Jan. 15, 2014
Jan. 8, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063